Compact RNA editors with small Cas13 proteins

Nat Biotechnol. 2022 Feb;40(2):194-197. doi: 10.1038/s41587-021-01030-2. Epub 2021 Aug 30.

Abstract

CRISPR-Cas13 systems have been developed for precise RNA editing, and can potentially be used therapeutically when temporary changes are desirable or when DNA editing is challenging. We have identified and characterized an ultrasmall family of Cas13b proteins-Cas13bt-that can mediate mammalian transcript knockdown. We have engineered compact variants of REPAIR and RESCUE RNA editors by functionalizing Cas13bt with adenosine and cytosine deaminase domains, and demonstrated packaging of the editors within a single adeno-associated virus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenosine / genetics
  • Adenosine Deaminase / genetics
  • Animals
  • CRISPR-Cas Systems* / genetics
  • Gene Editing
  • Mammals / genetics
  • RNA Editing / genetics
  • RNA* / genetics

Substances

  • RNA
  • Adenosine Deaminase
  • Adenosine